Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery-Reference-Cited by-同舟云学术

Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery

Published:2017-08 Issue: Volume:117 Page:212-223
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Morgen Michael,Saxena Ajay,Chen Xue-Qing,Miller Warren,Nkansah Richard,Goodwin Aaron,Cape Jon,Haskell Roy,Su Ching,Gudmundsson Olafur,Hageman Michael,Kumar Anoop,Chowan Gajendra Singh,Rao Abhijith,Holenarsipur Vinay K.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference51 articles.

1. Drug-like properties and the causes of poor solubility and poor permeability;Lipinski;J. Pharm. Tox. Methods,2000

2. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings;Lipinski;Adv. Drug Del. Rev.,2012

3. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs;Porter;Nat. Rev. Drug Disc.,2007

4. The application of discovery toxicology and pathology toward the design of safer pharmaceutical lead candidates;Kramer;Nat. Rev. Drug Disc.,2007

5. Micronization: a method of improving the bioavailability of poorly soluble drugs;Chaumeil;Methods Find. Exp. Clin. Pharmacol.,1998

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Lipophilic Salt Form to Enhance the Lipid Solubility and Certain Biopharmaceutical Properties of Lapatinib;Molecular Pharmaceutics;2024-06-27

2. Combination of co-amorphization with SNEDDS outperforms Ofev® in the oral absorption of nintedanib;International Journal of Pharmaceutics;2024-05

3. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation;International Journal of Pharmaceutics;2024-05

4. Utilization of Lipophilic Salt and Phospholipid Complex in Lipid-Based Formulations to Modulate Drug Loading and Oral Bioavailability of Pazopanib;AAPS PharmSciTech;2024-03-12

5. Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs;Molecular Pharmaceutics;2023-07-26